Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice

This publication has 58 references indexed in Scilit:

• Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
  Cell, 2005
• Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines
  Blood, 2004
• Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
  Nature Genetics, 2004
• Hematologic malignancies
  Current Opinion in Hematology, 2001
• Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis
  Oncogene, 2001
• Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation
  Oncogene, 1998
• Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
  Science, 1998
• Role of Aspartic Acid 814 in the Function and Expression of c-kit Receptor Tyrosine Kinase
  Published by Elsevier ,1996
• Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
  Journal of Clinical Investigation, 1993
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
  Nature, 1985